CDP323 Biomarker Study

Clinical trial NCT00726648 · COMPLETED

Trial details

NCT number: NCT00726648
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2008-07-01
Primary completion: 2009-03-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.